Potential role of ustekinumab in the treatment of chronic plaque psoriasis - Wikidata - awgldk - TriplyDB

Potential role of ustekinumab in the treatment of chronic plaque psoriasis

Potential role of ustekinumab in the treatment of chronic plaque psoriasis

http://www.wikidata.org/entity/Q33892602

about

Effect of Type 2 Diabetes Mellitus and Diabetic Nephropathy on IgG Pharmacokinetics and Subcutaneous Bioavailability in the Rat An Extended Minimal Physiologically Based Pharmacokinetic Model: Evaluation of Type II Diabetes Mellitus and Diabetic Nephropathy on Human IgG Pharmacokinetics in Rats

P2860

Q35768430-E3E6B7BE-AAEA-4ACE-9298-C4A3378307BD Q36232508-5F226DC8-C78D-4134-85D0-B8D3D4341A5D

P2860

Potential role of ustekinumab in the treatment of chronic plaque psoriasis

http://www.wikidata.org/entity/Q33892602

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Potential role of ustekinumab in the treatment of chronic plaque psoriasis

@ast

Potential role of ustekinumab in the treatment of chronic plaque psoriasis

@en

type

label

Potential role of ustekinumab in the treatment of chronic plaque psoriasis

@ast

Potential role of ustekinumab in the treatment of chronic plaque psoriasis

@en

prefLabel

Potential role of ustekinumab in the treatment of chronic plaque psoriasis

@ast

Potential role of ustekinumab in the treatment of chronic plaque psoriasis

@en

P1433

Q33892602-18418964-6192-4F27-A019-243974690A97

P1476

Q33892602-EA6BE2EB-EE81-42AD-AA62-C6E8DFAC1D62

P2093

Q33892602-7F323B36-DD03-49BC-A7CB-2EB9214BE203

Q33892602-E9092269-525D-41D0-A231-A9C40E1D8DDE

P2860

Q33892602-02E75A1A-3CC4-490E-A1A3-F6A85DB60BDC

Q33892602-040CD911-8A0E-4639-8CC9-F03B06BA37C1

Q33892602-062BC9D6-BACC-4305-8A4D-A0310F8EC8D0

Q33892602-06C81000-176C-4932-B6A1-D30E07709AFB

Q33892602-071FEBAE-0A65-4A05-895D-C9BF5282D57A

Q33892602-0750CBF7-295D-4770-AB81-C2C72739264A

Q33892602-14E984C3-9CBA-4E11-B91B-879A7ED6C590

Q33892602-18EABDEB-3876-47F3-97A0-4E8DC486A56A

Q33892602-264CCB66-1260-491A-A6A1-7AF8C300E41C

Q33892602-29FA7A5D-B7B9-4C66-8667-C23A9310B3AD

P304

Q33892602-AF806F7A-AA07-42A7-9C3B-7F95B8A84515

P31

Q33892602-F9CDF3AB-4920-48C7-868D-700392207D4B

P356

Q33892602-7B1236BA-A284-4F8E-ADC6-479D9D1B0BCB

P478

Q33892602-D9B15348-D866-460D-A072-DB22E0A0D1AD

P577

Q33892602-2FE085C9-2426-47F1-9EF1-CF85C310716A

P698

Q33892602-0113C459-EED0-4D7F-B8A8-6E3D36342778

P932

Q33892602-218CED52-6E06-4A9C-B6E4-FD21192B227A

P356

P1433

Biologics: Targets and Therapy

P1476

Potential role of ustekinumab in the treatment of chronic plaque psoriasis

@en

P2093

Luigi Naldi

http://www.w3.org/2001/XMLSchema#string

Santo Raffaele Mercuri

http://www.w3.org/2001/XMLSchema#string

P2860

Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12

A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R

Regulation of virus-induced IL-12 and IL-23 expression in human macrophages

Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients

Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways

Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris

IL-23 promotes tumour incidence and growth

Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

P304

119-129

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/BTT.S4921

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20531968

http://www.w3.org/2001/XMLSchema#string

P932

2880344

http://www.w3.org/2001/XMLSchema#string